Massive Bio rakes in $2.6m

New York City-based Massive Bio Inc, a provider of precision medicine and artificial intelligence-enabled patient centric clinical trial enrollment solutions, has secured $2.6 million in funding.

New York City-based Massive Bio Inc, a provider of precision medicine and artificial intelligence-enabled patient centric clinical trial enrollment solutions, has secured $2.6 million in funding. Revo Capital led the round with participation from Cavendish Impact Foundation.

Source: Press Release